Fukuda Denshi Co., Ltd.

Tokyo Stock Exchange 6960.T

Fukuda Denshi Co., Ltd. EBITDA for the year ending March 31, 2024: USD 242.78 M

Fukuda Denshi Co., Ltd. EBITDA is USD 242.78 M for the year ending March 31, 2024, a -3.61% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

Fukuda Denshi Co., Ltd. EBITDA for the year ending March 31, 2023 was USD 251.88 M, a -3.36% change year over year.
Fukuda Denshi Co., Ltd. EBITDA for the year ending March 31, 2022 was USD 260.63 M, a 2.45% change year over year.
Fukuda Denshi Co., Ltd. EBITDA for the year ending March 31, 2021 was USD 254.39 M, a 28.46% change year over year.
Fukuda Denshi Co., Ltd. EBITDA for the year ending March 31, 2020 was USD 198.03 M, a 7.10% change year over year.

Key data

Date	EBITDA	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)

Tokyo Stock Exchange: 6960.T

Fukuda Denshi Co., Ltd.

CEO	Mr. Kotaro Fukuda
IPO Date	Jan. 4, 2000
Location	Japan
Headquarters	2-35-8 Hongo
Employees	3,443
Sector	Healthcare
Industries Medical Instruments Hardware & Electronics Telehealth

Description

Fukuda Denshi Co., Ltd. engages in manufacture and sale of medical instruments in Japan and internationally. It offers resting electrocardiograph products; data management software; stress test products; and patient monitoring systems, including central and bedside monitors, transmitters, and central viewer workstations; and vascular screening systems. The company was founded in 1939 and is based in Tokyo, Japan.

Key trends

Past 5 years